T1	CHEM 8 18	paroxetina
#1	AnnotatorNotes T1	C0070122; paroxetine; Organic Chemical · Pharmacologic Substance
T2	DISO 32 50	eyaculación precoz
#2	AnnotatorNotes T2	C0033038; Premature Ejaculation; Mental or Behavioral Dysfunction
T3	ANAT 1717 1735	gastrointestinales
#3	AnnotatorNotes T3	C0012240; Gastrointestinal system; Body System
T4	DISO 107 125	Eyaculación precoz
#4	AnnotatorNotes T4	C0033038; Premature Ejaculation; Mental or Behavioral Dysfunction
T5	DISO 127 129	EP
#5	AnnotatorNotes T5	C0033038; Premature Ejaculation; Mental or Behavioral Dysfunction
T6	PROC 214 222	terapias
#6	AnnotatorNotes T6	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T7	CHEM 227 281	inhibidores selectivos de la recaptación de serotonina
#7	AnnotatorNotes T7	C0360105; Selective Serotonin Reuptake Inhibitors; Pharmacologic Substance
T8	PROC 304 323	evaluar la eficacia
#8	AnnotatorNotes T8	C1707887; Efficacy Study; Research Activity
T9	CHEM 327 337	paroxetina
#9	AnnotatorNotes T9	C0070122; paroxetine; Organic Chemical · Pharmacologic Substance
T10	PROC 343 354	tratamiento
#10	AnnotatorNotes T10	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T11	DISO 361 379	eyaculación precoz
#11	AnnotatorNotes T11	C0033038; Premature Ejaculation; Mental or Behavioral Dysfunction
T12	PROC 516 550	estudio prospectivo tipo crossover
#12	AnnotatorNotes T12	C0150097; Cross-Over Studies; Research Activity + C0033522; Prospective Studies; Research Activity
T13	DISO 580 582	EP
#13	AnnotatorNotes T13	C0033038; Premature Ejaculation; Mental or Behavioral Dysfunction
T14	ANAT 658 665	vaginal
#14	AnnotatorNotes T14	C0042232; Vagina; Body Part, Organ, or Organ Component | C1278985; Entire vagina; Body Part, Organ, or Organ Component
T15	CHEM 701 711	paroxetina
#15	AnnotatorNotes T15	C0070122; paroxetine; Organic Chemical · Pharmacologic Substance
T16	CHEM 750 760	paroxetina
#16	AnnotatorNotes T16	C0070122; paroxetine; Organic Chemical · Pharmacologic Substance
T17	CHEM 905 915	paroxetina
#17	AnnotatorNotes T17	C0070122; paroxetine; Organic Chemical · Pharmacologic Substance
T18	PROC 920 927	placebo
#18	AnnotatorNotes T18	C0032042; Placebos; Therapeutic or Preventive Procedure
T19	PROC 1016 1025	crossover
#19	AnnotatorNotes T19	C0150097; Cross-Over Studies; Research Activity
T20	PROC 979 1000	suspensión de terapia
#20	AnnotatorNotes T20	C0850893; stop medication; Therapeutic or Preventive Procedure
T21	PROC 1270 1281	tratamiento
#21	AnnotatorNotes T21	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T22	CHEM 1335 1345	paroxetina
#22	AnnotatorNotes T22	C0070122; paroxetine; Organic Chemical · Pharmacologic Substance
T23	DISO 1752 1776	disminución de la líbido
#23	AnnotatorNotes T23	C0011124; Decreased Libido; Finding
T24	PROC 1391 1398	placebo
#24	AnnotatorNotes T24	C0032042; Placebos; Therapeutic or Preventive Procedure
T25	PROC 1512 1519	placebo
#25	AnnotatorNotes T25	C0032042; Placebos; Therapeutic or Preventive Procedure
T26	CHEM 1561 1571	paroxetina
#26	AnnotatorNotes T26	C0070122; paroxetine; Organic Chemical · Pharmacologic Substance
T27	CHEM 1623 1633	paroxetina
#27	AnnotatorNotes T27	C0070122; paroxetine; Organic Chemical · Pharmacologic Substance
T28	DISO 1685 1704	Reacciones adversas
#28	AnnotatorNotes T28	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T29	DISO 1706 1735	trastornos gastrointestinales
#29	AnnotatorNotes T29	C0017178; Gastrointestinal Diseases; Disease or Syndrome
T30	DISO 1818 1826	anorexia
#30	AnnotatorNotes T30	C0003123; Anorexia; Disease or Syndrome | C1971624; Loss of appetite (finding); Finding
T31	PROC 1851 1862	tratamiento
#31	AnnotatorNotes T31	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T32	DISO 1869 1887	eyaculación precoz
#32	AnnotatorNotes T32	C0033038; Premature Ejaculation; Mental or Behavioral Dysfunction
T33	CHEM 1892 1902	paroxetina
#33	AnnotatorNotes T33	C0070122; paroxetine; Organic Chemical · Pharmacologic Substance
T34	CHEM 1286 1296	paroxetina
#34	AnnotatorNotes T34	C0070122; paroxetine; Organic Chemical · Pharmacologic Substance
T35	PROC 1366 1373	placebo
#35	AnnotatorNotes T35	C0032042; Placebos; Therapeutic or Preventive Procedure
T36	PROC 1454 1479	administración de placebo
#36	AnnotatorNotes T36	C3897898; Placebo Administration; Therapeutic or Preventive Procedure
T37	Duration 417 426	4-6 horas
T38	PHYS 437 442	coito
#37	AnnotatorNotes T38	C0009253; Coitus; Organism Function
T39	Frequency 474 480	diaria
T40	LIVB 483 492	Pacientes
#38	AnnotatorNotes T40	C0030705; Patients; Patient or Disabled Group
T41	LIVB 569 578	pacientes
#39	AnnotatorNotes T41	C0030705; Patients; Patient or Disabled Group
T42	Duration 631 640	un minuto
T43	LIVB 683 692	pacientes
#40	AnnotatorNotes T43	C0030705; Patients; Patient or Disabled Group
T44	Dose 712 717	20 mg
T45	Duration 725 737	tres semanas
T46	Dose 761 766	20 mg
T47	Duration 767 776	4-6 horas
T48	Duration 808 820	tres semanas
T49	LIVB 848 857	pacientes
#41	AnnotatorNotes T49	C0030705; Patients; Patient or Disabled Group
T50	Duration 963 975	tres semanas
T55	Duration 1202 1213	0.4 minutos
T56	Duration 1252 1263	4.3 minutos
T57	Frequency 1297 1303	diaria
T58	Duration 1305 1316	5.8 minutos
T59	Frequency 1374 1380	diario
T60	Frequency 1480 1486	diario
T61	Duration 1494 1505	0.8 minutos
T62	Duration 1537 1548	1.1 minutos
T63	Frequency 1572 1583	diariamente
T64	Duration 1660 1671	6.1 minutos
T65	LIVB 1741 1750	pacientes
#42	AnnotatorNotes T65	C0030705; Patients; Patient or Disabled Group
T68	Frequency 1912 1918	diaria
T69	PHYS 32 43	eyaculación
#43	AnnotatorNotes T69	C0013746; Ejaculation; Organism Function
T70	PHYS 107 118	Eyaculación
#44	AnnotatorNotes T70	C0013746; Ejaculation; Organism Function
T71	PHYS 256 267	recaptación
#45	AnnotatorNotes T71	C0599702; reuptake; Cell Function
T72	PHYS 361 372	eyaculación
#46	AnnotatorNotes T72	C0013746; Ejaculation; Organism Function
T73	PHYS 787 803	encuentro sexual
#47	AnnotatorNotes T73	C0009253; Coitus; Organism Function
T74	PHYS 1869 1880	eyaculación
#48	AnnotatorNotes T74	C0013746; Ejaculation; Organism Function
T75	PHYS 646 665	penetración vaginal
#49	AnnotatorNotes T75	C0009253; Coitus; Organism Function
T76	Frequency 718 720	/d
T51	Date 1180 1194	pretratamiento
#50	AnnotatorNotes T51	C1882440; Pre-Therapy; Temporal Concept | C3539075; Pretreatment Period; Temporal Concept
T52	Duration 1358 1361	0.9
T53	Duration 1383 1386	0.6
T54	Duration 1598 1601	3.3
T66	CONC 1785 1791	afectó
A1	Assertion T66 Negated
T67	Neg_cue 1782 1784	no
R1	Negation Arg1:T67 Arg2:T66	
T77	Observation 1045 1065	frecuencias coitales
#51	AnnotatorNotes T77	C0278108; Frequency of sexual intercourse; Finding 
T78	Observation 1792 1809	frecuencia coital
#52	AnnotatorNotes T78	C0278108; Frequency of sexual intercourse; Finding
#53	AnnotatorNotes T66	C0521102; Interferes with; Functional Concept
T79	CONC 1068 1099	tiempo de latencia eyaculatoria
T80	Quantifier_or_Qualifier 19 28	a demanda
#54	AnnotatorNotes T80	C0679686; treatment on demand; Intellectual Product | C1879743; As Much as Desired; Qualitative Concept
R3	Has_Quantifier_or_Qualifier Arg1:T1 Arg2:T80	
T81	Quantifier_or_Qualifier 1399 1408	a demanda
#55	AnnotatorNotes T81	C0679686; treatment on demand; Intellectual Product | C1879743; As Much as Desired; Qualitative Concept
R4	Has_Quantifier_or_Qualifier Arg1:T24 Arg2:T81	
T82	Quantifier_or_Qualifier 1346 1356	a demanada
#56	AnnotatorNotes T82	C0679686; treatment on demand; Intellectual Product | C1879743; As Much as Desired; Qualitative Concept
R5	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T82	
T83	Quantifier_or_Qualifier 1634 1643	a demanda
#57	AnnotatorNotes T83	C0679686; treatment on demand; Intellectual Product | C1879743; As Much as Desired; Qualitative Concept
R6	Has_Quantifier_or_Qualifier Arg1:T27 Arg2:T83	
T84	Quantifier_or_Qualifier 1932 1941	a demanda
#58	AnnotatorNotes T84	C0679686; treatment on demand; Intellectual Product | C1879743; As Much as Desired; Qualitative Concept
T85	Quantifier_or_Qualifier 1520 1529	a demanda
#59	AnnotatorNotes T85	C0679686; treatment on demand; Intellectual Product | C1879743; As Much as Desired; Qualitative Concept
R7	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T85	
R10	Used_for Arg1:T7 Arg2:T6	
R11	Used_for Arg1:T9 Arg2:T10	
R13	Before Arg1:T9 Arg2:T38	
R14	Overlap Arg1:T9 Arg2:T37	
R15	Has_Frequency Arg1:T9 Arg2:T39	
T86	Quantifier_or_Qualifier 380 415	administrada sólo ante la necesidad
#60	AnnotatorNotes T86	C0679686; treatment on demand; Intellectual Product | C1879743; As Much as Desired; Qualitative Concept
R16	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T86	
R17	Has_Duration_or_Interval Arg1:T13 Arg2:T42	
R18	Before Arg1:T75 Arg2:T13	
R19	Location_of Arg1:T14 Arg2:T75	
R20	Experiences Arg1:T43 Arg2:T15	
R21	Before Arg1:T15 Arg2:T16	
R22	Has_Dose_or_Strength Arg1:T15 Arg2:T44	
R23	Has_Frequency Arg1:T15 Arg2:T76	
R24	Has_Duration_or_Interval Arg1:T15 Arg2:T45	
R25	Has_Dose_or_Strength Arg1:T16 Arg2:T46	
R26	Has_Duration_or_Interval Arg1:T16 Arg2:T47	
R27	Has_Duration_or_Interval Arg1:T16 Arg2:T48	
R28	Before Arg1:T16 Arg2:T73	
R29	Experiences Arg1:T43 Arg2:T16	
R30	Experiences Arg1:T49 Arg2:T18	
R31	Before Arg1:T20 Arg2:T19	
R32	Overlap Arg1:T19 Arg2:T50	
T87	CONC 1107 1124	test de t student
#61	AnnotatorNotes T87	C0871453; Students T Test; Intellectual Product
T88	CONC 1142 1173	tiempo de latencia eyaculatoria
R33	Overlap Arg1:T88 Arg2:T51	
R34	Has_Duration_or_Interval Arg1:T88 Arg2:T55	
R35	Used_for Arg1:T34 Arg2:T21	
R36	Has_Frequency Arg1:T34 Arg2:T57	
R37	Has_Frequency Arg1:T35 Arg2:T59	
R38	Has_Frequency Arg1:T36 Arg2:T60	
T89	CONC 1232 1235	TLE
R39	Has_Duration_or_Interval Arg1:T89 Arg2:T56	
R40	Has_Duration_or_Interval Arg1:T89 Arg2:T58	
R41	Has_Duration_or_Interval Arg1:T89 Arg2:T52	
R42	Has_Duration_or_Interval Arg1:T89 Arg2:T53	
T90	CONC 1439 1442	TLE
R43	Has_Duration_or_Interval Arg1:T90 Arg2:T61	
R44	Has_Duration_or_Interval Arg1:T90 Arg2:T62	
R45	Has_Frequency Arg1:T26 Arg2:T63	
T91	CONC 1587 1590	TLE
R46	Has_Duration_or_Interval Arg1:T91 Arg2:T54	
R47	Has_Duration_or_Interval Arg1:T91 Arg2:T64	
R48	Location_of Arg1:T3 Arg2:T29	
R49	Experiences Arg1:T65 Arg2:T28	
R50	Experiences Arg1:T65 Arg2:T29	
R51	Experiences Arg1:T65 Arg2:T23	
R52	Experiences Arg1:T65 Arg2:T78	
R53	Experiences Arg1:T65 Arg2:T30	
R54	Overlap Arg1:T23 Arg2:T78	
R56	Has_Frequency Arg1:T33 Arg2:T68	
R57	Used_for Arg1:T33 Arg2:T31	
R58	Has_Quantifier_or_Qualifier Arg1:T33 Arg2:T84	
T92	CONC 1175 1178	TLE
R2	Overlap Arg1:T92 Arg2:T51	
R8	Has_Duration_or_Interval Arg1:T92 Arg2:T55	
A2	Experiencer T65 Patient
A3	Experiencer T40 Patient
A4	Experiencer T41 Patient
A5	Experiencer T43 Patient
A6	Experiencer T49 Patient
